MOSAIC IMMUNOENGINEERING, INC.: net income or loss
Net income or loss for MOSAIC IMMUNOENGINEERING, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All MOSAIC IMMUNOENGINEERING, INC. financial histories
What this measure means
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
Exact concept: us-gaap:NetIncomeLoss. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-06-01 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | -687,846 | USD | 2026-04-15 | 10-K · 0001683168-26-002977 |
| 2024-01-01 | 2024-12-31 | -921,983 | USD | 2026-04-15 | 10-K · 0001683168-26-002977 |
| 2023-01-01 | 2023-12-31 | -1,008,235 | USD | 2025-04-15 | 10-K · 0001683168-25-002584 |
| 2022-01-01 | 2022-12-31 | -2,380,870 | USD | 2024-04-15 | 10-K · 0001683168-24-002402 |
| 2021-01-01 | 2021-12-31 | -3,684,478 | USD | 2023-03-02 | 10-K · 0001683168-23-001237 |
| 2019-06-01 | 2020-05-31 | -1,060,528 | USD | 2020-08-24 | 10-K · 0001683168-20-002849 |
| 2018-06-01 | 2019-05-31 | -798,463 | USD | 2020-08-24 | 10-K · 0001683168-20-002849 |
| 2017-06-01 | 2018-05-31 | -1,209,450 | USD | 2019-08-29 | 10-K · 0001683168-19-002782 |
| 2016-06-01 | 2017-05-31 | -45,368 | USD | 2018-08-29 | 10-K · 0001683168-18-002555 |
| 2015-06-01 | 2016-05-31 | -1,266,600 | USD | 2017-08-29 | 10-K · 0001683168-17-002239 |
| 2014-06-01 | 2015-05-31 | -1,538,028 | USD | 2016-08-29 | 10-K · 0001019687-16-007390 |
| 2013-06-01 | 2014-05-31 | -1,466,867 | USD | 2015-08-31 | 10-K · 0001019687-15-003312 |
| 2012-06-01 | 2013-05-31 | 1,096,215 | USD | 2014-08-19 | 10-K · 0001019687-14-003277 |
| 2011-06-01 | 2012-05-31 | -4,820,405 | USD | 2013-08-23 | 10-K · 0001019687-13-003304 |
| 2010-06-01 | 2011-05-31 | -11,515,390 | USD | 2012-08-29 | 10-K · 0001019687-12-003037 |
Related financial histories
- MOSAIC IMMUNOENGINEERING, INC.: total assets
- MOSAIC IMMUNOENGINEERING, INC.: total liabilities
- MOSAIC IMMUNOENGINEERING, INC.: stockholders equity
- MOSAIC IMMUNOENGINEERING, INC.: cash and cash equivalents
- MOSAIC IMMUNOENGINEERING, INC.: operating cash flow
- MOSAIC IMMUNOENGINEERING, INC.: capital expenditure payments
- MOSAIC IMMUNOENGINEERING, INC.: financing cash flow
- MOSAIC IMMUNOENGINEERING, INC.: investing cash flow
- MOSAIC IMMUNOENGINEERING, INC.: retained earnings or deficit
- MOSAIC IMMUNOENGINEERING, INC.: basic weighted-average shares
- MOSAIC IMMUNOENGINEERING, INC.: diluted weighted-average shares
- MOSAIC IMMUNOENGINEERING, INC.: basic earnings per share
- MOSAIC IMMUNOENGINEERING, INC.: diluted earnings per share
- MOSAIC IMMUNOENGINEERING, INC.: income tax expense or benefit
- MOSAIC IMMUNOENGINEERING, INC.: net property, plant and equipment
- MOSAIC IMMUNOENGINEERING, INC.: share-based compensation expense
- MOSAIC IMMUNOENGINEERING, INC.: operating income or loss
- MOSAIC IMMUNOENGINEERING, INC.: current assets
- MOSAIC IMMUNOENGINEERING, INC.: current liabilities
- MOSAIC IMMUNOENGINEERING, INC.: current accounts payable
- MOSAIC IMMUNOENGINEERING, INC.: common-stock repurchase payments
- MOSAIC IMMUNOENGINEERING, INC.: operating expenses
- MOSAIC IMMUNOENGINEERING, INC.: selling, general and administrative expense
- MOSAIC IMMUNOENGINEERING, INC.: research and development expense
Inspect the source
- Entity
- MOSAIC IMMUNOENGINEERING, INC. / CIK 0000836564
- Captured
- 2026-09-19T15:08:56.564Z
- SEC response SHA-256
20b7dbddee8b1aee5cb56cb4cf5c3c14c36ef1fafb538ec0211cfb2585ddf3fd
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000836564.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))